Literature DB >> 32776283

The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Regine Schneider-Stock1, Domenico Ribatti2.   

Abstract

In the last decade, the chicken chorioallantoic membrane (CAM) assay has been re-discovered in cancer research to study the molecular mechanisms of anti-cancer drug effects. Literature about the CAM assay as an alternative in vivo cancer xenograft model according to the 3R principles has exploded in the last 3 years. Following a summary of the basic knowledge about the chicken embryo, we compare advantages and disadvantages with the classical mouse xenograft model, exemplify established and innovative imaging techniques that are used in the CAM model, and give examples of its successful utilization for studying major hallmarks of cancer such as angiogenesis, proliferation, invasion, and metastasis.

Entities:  

Keywords:  3R model; Angiogenesis; Anti-angiogenesis; CAM model; CAM xenografts; Chorioallantoic membrane; Drug delivery; In vivo model; Metastasis; Tumor growth

Year:  2021        PMID: 32776283     DOI: 10.1007/164_2020_375

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  81 in total

1.  Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

2.  Angiogenesis induction by tumors, embryonic tissues, and lymphocytes.

Authors:  R Auerbach; L Kubai; Y Sidky
Journal:  Cancer Res       Date:  1976-09       Impact factor: 12.701

3.  Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.

Authors:  Chiara Brignole; Danilo Marimpietri; Fabio Pastorino; Beatrice Nico; Daniela Di Paolo; Michela Cioni; Federica Piccardi; Michele Cilli; Annalisa Pezzolo; Maria Valeria Corrias; Vito Pistoia; Domenico Ribatti; Gabriella Pagnan; Mirco Ponzoni
Journal:  J Natl Cancer Inst       Date:  2006-08-16       Impact factor: 13.506

4.  Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Dev Biol       Date:  1974-06       Impact factor: 3.582

5.  Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation.

Authors:  Maike Busch; Jan Große-Kreul; Janina Jasmin Wirtz; Manfred Beier; Harald Stephan; Brigitte Royer-Pokora; Klaus Metz; Nicole Dünker
Journal:  Int J Cancer       Date:  2017-05-19       Impact factor: 7.396

6.  Transepithelial invasion and intramesenchymal infiltration of the chick embryo chorioallantois by tumor cell lines.

Authors:  P B Armstrong; J P Quigley; E Sidebottom
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

7.  Development of a green fluorescent protein metastatic-cancer chick-embryo drug-screen model.

Authors:  Vladimir Bobek; Jiri Plachy; Daniela Pinterova; Katarina Kolostova; Michael Boubelik; Ping Jiang; Meng Yang; Robert M Hoffman
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

8.  Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.

Authors:  Neringa Balciūniene; Arimantas Tamasauskas; Angelija Valanciūte; Vytenis Deltuva; Gintautas Vaitiekaitis; Inga Gudinaviciene; Joachim Weis; Dietrich Graf von Keyserlingk
Journal:  Medicina (Kaunas)       Date:  2009       Impact factor: 2.430

9.  Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells.

Authors:  Julian Böhm; Julienne Kathrin Muenzner; Aylin Caliskan; Benardina Ndreshkjana; Katharina Erlenbach-Wünsch; Susanne Merkel; Roland Croner; Tilman T Rau; Carol Immanuel Geppert; Arndt Hartmann; Adriana Vial Roehe; Regine Schneider-Stock
Journal:  J Cancer Res Clin Oncol       Date:  2019-07-17       Impact factor: 4.553

10.  Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.

Authors:  Maike Busch; David Papior; Harald Stephan; Nicole Dünker
Journal:  Oncol Rep       Date:  2017-11-16       Impact factor: 3.906

View more
  9 in total

1.  Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model.

Authors:  Philipp Kunze; Lucas Kreiss; Vendula Novosadová; Adriana V Roehe; Sara Steinmann; Jan Prochazka; Carol I Geppert; Arndt Hartmann; Sebastian Schürmann; Oliver Friedrich; Regine Schneider-Stock
Journal:  Cancers (Basel)       Date:  2022-05-10       Impact factor: 6.575

2.  Treatment Effect of a Vascular-Disrupting Agent Dynamically Monitored by DWI: An Animal Experimental Study.

Authors:  Danping Huang; Ruimeng Yang; Yong Zou; Hongmei Lin; Xiangdong Xu; Xinhua Wei; Hanzheng Chang; Liqiong Wu; Wenshuang Ding; Wenjie Tang; Xinqing Jiang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-12-30

3.  Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma.

Authors:  Fani Karagianni; Christina Piperi; Berta Casar; Dalia de la Fuente-Vivas; Rocío García-Gómez; Kyriaki Lampadaki; Vasiliki Pappa; Evangelia Papadavid
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

4.  Chorioallantoic membrane tumor models highlight the effects of cisplatin compounds in oral carcinoma treatment.

Authors:  Patrizia Sarogni; Ana Katrina Mapanao; Alessandra Gonnelli; Maria Laura Ermini; Sabrina Marchetti; Claudia Kusmic; Fabiola Paiar; Valerio Voliani
Journal:  iScience       Date:  2022-02-24

5.  Retinoblastoma Cell Growth In Vitro and Tumor Formation In Ovo-Influence of Different Culture Conditions.

Authors:  Annika Doege; Rebecca Steens; Nicole Dünker; Maike Anna Busch
Journal:  Methods Protoc       Date:  2022-03-02

Review 6.  3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model.

Authors:  Eric Pion; Julia Karnosky; Sofie Boscheck; Benedikt J Wagner; Katharina M Schmidt; Stefan M Brunner; Hans J Schlitt; Thiha Aung; Christina Hackl; Silke Haerteis
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

7.  A Novel Artificial Intelligence-Based Approach for Quantitative Assessment of Angiogenesis in the Ex Ovo CAM Model.

Authors:  Lorenz Faihs; Bardia Firouz; Paul Slezak; Cyrill Slezak; Michael Weißensteiner; Thomas Ebner; Nassim Ghaffari Tabrizi-Wizsy; Kurt Schicho; Peter Dungel
Journal:  Cancers (Basel)       Date:  2022-09-01       Impact factor: 6.575

8.  PD-1/PD-L1 Checkpoint Inhibitors Are Active in the Chicken Embryo Model and Show Antitumor Efficacy In Ovo.

Authors:  Yan Wang; Xavier Rousset; Chloé Prunier; Paul Garcia; Emilien Dosda; Estelle Leplus; Jean Viallet
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

9.  Downregulation of m6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.

Authors:  Catarina Guimarães-Teixeira; João Lobo; Vera Miranda-Gonçalves; Daniela Barros-Silva; Cláudia Martins-Lima; Sara Monteiro-Reis; José Pedro Sequeira; Isa Carneiro; Margareta P Correia; Rui Henrique; Carmen Jerónimo
Journal:  Mol Oncol       Date:  2022-03-24       Impact factor: 7.449

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.